Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongxiening Granule
- Development stage
- Unknown
- Lead developer
- The First Affiliated Hospital of USTC
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tongxiening Granule is a Traditional Chinese Medicine (TCM) formulation developed by researchers at Anhui Provincial Hospital for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D). Derived from the classic "Tongxie Yaofang" formula, it consists of four primary herbal components: *Atractylodes macrocephala*, *Paeonia lactiflora*, *Citrus reticulata*, and *Saposhnikovia divaricata*. The drug works through multiple pathways, including the reduction of visceral hypersensitivity, modulation of the brain-gut axis (specifically targeting 5-hydroxytryptamine levels), and restoration of gut microbiota balance. Clinical studies have demonstrated its efficacy in improving abdominal pain and stool consistency in IBS-D patients by regulating inflammatory cytokines and intestinal barrier function.
- Brand names
- Tongxiening Granule
- Other names
- Tong-Xie-NingTongxiening
02
Targets
IL-6 (Interleukin 6)5-HT2 (5-HT2 receptor family)TJP1 (Tight junction protein 1 (ZO-1))CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Tongxiening Granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tongxiening Granule.